{
    "2019-05-14": [
        [
            {
                "time": "2023-10-18",
                "original_text": "Top Research Reports for Alphabet, Eli Lilly & CVS Health",
                "features": {
                    "keywords": [
                        "Alphabet",
                        "Eli Lilly",
                        "CVS Health",
                        "Research Reports"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "technology",
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-18",
                "original_text": "Lilly's Cyramza Gets FDA Nod for Second-Line Liver Cancer",
                "features": {
                    "keywords": [
                        "Lilly",
                        "Cyramza",
                        "FDA",
                        "Liver Cancer"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}